Tim McCarthy talks to Proactive Investors – 6th February 2017

6th February 2017 - 4:24 pm

Tim McCarthy, chairman of ImmuPharma PLC (LON:IMM) spoke to Proactive Investors to give an update on the company’s progress with its phase-III clinical trial of Lupuzor™, a treatment for Lupus – a life threatening auto-immune disease.



Share this article